Add to a list

Inactive Instrument

genOway SA Stock Xetra

JEH

FR0004053510

Biotechnology & Medical Research

OTC Markets Traded

End-of-day quote Xetra Other stock markets
- ^EUR	-

03-30	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-30	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Analysts' recommendations: genOway SA

23-11-22	GenOway: sharp rise, broker initiates buy recommendation
23-11-22	GenOway: Euroland initiates buy coverage

More recommendations

News in other languages: genOway SA

06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
06-03	GenOway : 20260626 Avis de convocation
06-03	GenOway : 20260626 Demande d’envoi de documents et de renseignements
05-05	GenOway : 20260505 Rapport de gestion du conseil d’administration
04-14	GenOway poursuit son développement international : lancement d’un modèle de « Franchises genOway » avec l’ouverture des deux premières au Canada et en Australie

More news

Managers and Directors: genOway SA

Manager	Title	Age	Since
Christian Grenier CEO	Chief Executive Officer	-	-
Alexandre Fraichard COO	Chief Operating Officer	-	1999-02-28
Benjamin Bruneau DFI	Director of Finance/CFO	-	2015-09-30

Director	Title	Age	Since
Alexandre Fraichard BRD	Director/Board Member	-	1999-02-28
Christian Grenier CHM	Chairman	-	-
Laurent Fraisse BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.44%	+1.71%	-10.63%	-9.16%	43.13B
REVOLUTION MEDICINES, INC.	+3.31%	+5.93%	+308.19%	+562.02%	34.65B
BEONE MEDICINES AG	+2.84%	+2.14%	+6.87%	+34.93%	30.03B
IQVIA HOLDINGS INC.	-1.70%	-7.54%	+8.51%	-22.34%	28B
CELLTRION, INC.	-1.90%	-1.56%	+11.62%	+19.80%	24.45B
ASCENDIS PHARMA A/S	-0.14%	+5.86%	-	-	14.34B
MEDPACE HOLDINGS, INC.	+0.68%	-1.53%	+52.04%	+107.47%	13.14B
EUROFINS SCIENTIFIC SE	-0.57%	-2.43%	+5.18%	+4.20%	12.53B
IONIS PHARMACEUTICALS, INC.	-0.26%	+1.15%	+100.27%	+80.69%	12.25B
Average	+0.41%	+0.73%	+60.26%	+97.20%	23.61B
Weighted average by Cap.	+0.77%	+1.27%	+65.22%	+113.23%

See all sector performances

genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).

Employees

Sector

Biotechnology & Medical Research

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	21.67M 24.85M 20.07M 18.79M 35.23M 2.34B 35.44M 238M 92.26M 1.15B 93.28M 91.28M 4.01B	P/E 2024 *	-	P/E 2025	-
Enterprise Value	28.39M 32.56M 26.29M 24.61M 46.16M 3.07B 46.43M 312M 121M 1.51B 122M 120M 5.25B	EV / Sales 2024	1.28x	EV / Sales 2025	1.11x
Free-Float	79.77%	Yield 2024 *	-	Yield 2025	-

03-30	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-30	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI
12-15	GenOway Société anonyme agreed to acquire Data Science and AI assets in OMICS platform for ?7 million.	CI
11-19	GenOway Soars 18% on Strong Momentum from Chinese Joint Venture
25-09-24	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-03-27	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-09-23	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-19	GenOway: 15% growth in first-half sales
23-11-22	GenOway: sharp rise, broker initiates buy recommendation
23-11-22	GenOway: Euroland initiates buy coverage
23-10-17	GenOway: creation of a joint venture in Shanghai
23-09-22	GenOway: profitability target achieved ahead of schedule
23-09-20	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

03-16	GenOway : 20250627 Avis de convocation	PU
11-18	Accélération du développement en Chine : la coentreprise genOway Shanghai devient un moteur clé de croissance pour le Groupe	PU
25-09-22	GenOway : Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%	PU
24-03-27	GenOway : Résultats annuels 2023	PU
23-09-22	GenOway : Résultats du 1er semestre 2023	PU

	2024	2025
Net sales	27.53M 31.58M 25.5M 23.87M 44.77M 2.98B 45.04M 302M 117M 1.47B 119M 116M 5.09B	28.6M 32.8M 26.49M 24.8M 46.51M 3.1B 46.79M 314M 122M 1.52B 123M 120M 5.29B
Net income	1.83M 2.1M 1.7M 1.59M 2.98M 198M 2.99M 20.11M 7.8M 97.52M 7.88M 7.71M 339M	928K 1.06M 859K 804K 1.51M 100M 1.52M 10.19M 3.95M 49.42M 3.99M 3.91M 172M
Net Debt	623K 715K 577K 540K 1.01M 67.42M 1.02M 6.84M 2.65M 33.18M 2.68M 2.62M 115M	6.72M 7.71M 6.22M 5.82M 10.92M 727M 10.99M 73.81M 28.61M 358M 28.92M 28.3M 1.24B

genOway SA Stock Xetra

Stocks

JEH

FR0004053510

Biotechnology & Medical Research

Valuation: genOway SA

Latest news : genOway SA

Analysts' recommendations: genOway SA

Press Releases: genOway SA

News in other languages: genOway SA

Managers and Directors: genOway SA

Other Biotechnology & Medical Research

Financials

Company Profile